RS

Ritu Sahni

Director Director DIN 07061171
DIN 07061171 First appointment Feb 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2015
Shareholding value Locked Premium profile

About Ritu Sahni

Ritu Sahni has 11 years in corporate governance. Formerly with 1 company, such as Bion Pharmaceutics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07061171
Primary Designation Director
First Appointment 25 Feb 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Bion Pharmaceutics Private Limited U24100DL2015PTC277147
Director 25 Feb 2015 2015 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bion Pharmaceutics Private Limited
Premium access

Shareholding and investment profile for Ritu Sahni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Sahni

Ritu Sahni has 11 years in corporate governance. Formerly with 1 company, such as Bion Pharmaceutics Private Limited. Engaged in General Business. Contributes to corporate operations.

Ritu Sahni is associated with 0 companies as a director.

Ritu Sahni has expertise in General Business.

Ritu Sahni has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available